李勇杰, 于庆龙, 潘际刚. Impacts of ethanol on the epidermal growth factor receptor (EGFR) -calpain signaling and migration in breast cancer cells[J]. China Oncology, 2016, 26(10): 820-825.
李勇杰, 于庆龙, 潘际刚. Impacts of ethanol on the epidermal growth factor receptor (EGFR) -calpain signaling and migration in breast cancer cells[J]. China Oncology, 2016, 26(10): 820-825. DOI: 10.19401/j.cnki.1007-3639.2016.10.003.
Background and purpose: Ethanol has been reported to stimulate progression of breast cancer
yet the underlying mechanism is not fully understood. This study aimed to investigate effects of ethyl alcohol (EtOH) on the calcium-activated neutral protease (CANP)-cyclin E/focal adhesion kinase (FAK) signaling and cell migration in breast cancer cells
as well as the role of epidermal growth factor receptor (EGFR) in the EtOH-stimulated effects
in order to assess the signaling mechanism(s) underlying how EtOH enhances cancer progression. Methods: Human breast cancer cell line MCF-7 was employed as a model system
with MCF-10A mammary epithelial cells as control. In vitro wound healing assay was carried out to evaluate EtOH-induced cell migration. The effects of EtOH or epidermal growth factor on the proteolysis of cyclin E/FAK were detected by Western blot. EGFR inhibitor (EGFR-I) and a specific inhibitor for CANP
Calpeptin
were applied to pretreat cultured cells to explore their influences on the cell migration and cyclin E/FAK proteolysis triggered by EtOH. Results: Treatment of model cells with EtOH (0.3%) stimulated significant proteolysis of cyclin E/FAK in a dose-/time-dependent manner and increased migration (+47.30%
P0.05) in MCF-7 breast cancer cells
but had no significant effect on migration in MCF-10A cells. Pretreatment with Calpeptin (10 μmol/L) significantly reduced EtOH (0.3%)- or EGFR (10 ng/mL)-induced cyclin E/FAK truncation. EGFR-I (3 μmol/L) profoundly reduced EtOH-indcued CANP dependent proteolysis of CANP1 and cyclin E/FAK as well as cell migration (-53.00%
P0.01). Conclusion: EtOH significantly stimulates activation of CANP via EGFR pathway
resulting in proteolysis of cyclin E/FAK and migration in MCF-7 breast cancer cells
suggesting EGFR-CANP signaling to be a potential target for suppression of metastasis in breast cancer.